Metabolon - About the company
Metabolon is a series H company based in Morrisville (United States), founded in 2000. It operates as a Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine. Metabolon has raised $166M in funding from investors like Sevin Rosen, Fletcher Spaght and Fulcrum Financial Group. The company has 86 active competitors, including 28 funded and 17 that have exited. Its top competitors include companies like Maze Therapeutics, Alector and Seer.
Company Details
Provider of solutions for biomarker discovery, diagnostic tests, and personalized medicine. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. It also offers Quantose IR, a lab test for prediabetes assessment and treatment, and Meta IMD, a CLIA assay for inborn errors of metabolism. The company is also developing metabolomics-based clinical diagnostic tests that may improve the early detection of obesity-related metabolic diseases.
- Website
- Social
Key Metrics
Founded Year
2000
Location
Morrisville, United States
Stage
Series H
Total Funding
in 19 rounds
Latest Funding Round
Investors
Ranked
1st among 86 active competitors
Employee Count
as on Dec 31, 2022
Similar Companies
Legal entities associated with Metabolon
Metabolon is associated with 2 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Apr 17, 2017 | - | 249 | 271 | |
Dec 31, 1999 | - | 152 | 370 |
Get your free copy of Metabolon's company profile
Metabolon's funding and investors
Metabolon has raised a total funding of $166M over 19 rounds. Its first funding round was on Mar 2003.
Metabolon has 18 institutional investors including Sevin Rosen, Fletcher Spaght and Fulcrum Financial Group.
Here is the list of recent funding rounds of Metabolon:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Dec 31, 2024 | $7.5M | Series H | 8026161 | 4748068 | - |
May 01, 2024 | $298K | Grant (prize money) | 7011308 | 4205981 | |
Sep 18, 2023 | $298K | Grant (prize money) | 6061562 | 6327072 |
Access funding benchmarks and valuations. Sign up today!View details of Metabolon's funding rounds and investors
Metabolon's founders and board of directors
Metabolon's employee count trend
Metabolon has 189 employees as of Dec 22. The total employee count is 20.4% more than what it was in Dec 21. Here is Metabolon's employee count trend over the years:
Uncover Metabolon's growth story! Sign up today!Metabolon's Competitors and alternates
Top competitors of Metabolon include Maze Therapeutics, Alector and Seer. Here is the list of Top 10 competitors of Metabolon, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | 2000, Morrisville (United States), Series H | Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine | $166M | Perceptive Advisors, ATEL Capital GroupÌý&²¹³¾±è;Ìý | 67/100 |
2nd | Maze Therapeutics 2018, Redwood City (United States), Public | Developer of genetic bio-markers in neurological, metabolic, and renal diseases | $496M | Foresite Capital, Arch Venture PartnersÌý&²¹³¾±è;Ìý | 71/100 |
3rd |  Alector 2013, San Francisco (United States), Public | Developing immuno-modulatory therapies for dementia and other neurodegenerative disorders | $215M | New Leaf Venture Partners, Foresite CapitalÌý&²¹³¾±è;Ìý | 70/100 |
4th | Seer 2017, San Francisco (United States), Public | Developer of proteomics platform for early detection of cancer and neurological diseases | $128M | T. Rowe Price, HBM Healthcare InvestmentsÌý&²¹³¾±è;Ìý | 67/100 |
5th |  Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | Third Rock Ventures, Casdin CapitalÌý&²¹³¾±è;Ìý | 66/100 |
6th | NeoPhore 2017, Cambridge (United Kingdom), Series B | Developer of small molecule therapies to treat cancer | $44.6M | Astellas Venture Management, ParkwalkÌý&²¹³¾±è;Ìý | 63/100 |
7th | Scailyte 2017, Lucerne (Switzerland), Series A | Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery | $20.3M | Zurcher Kantonalbank, MassChallengeÌý&²¹³¾±è;Ìý | 61/100 |
8th | Lexicon Pharmaceuticals 1995, The Woodlands (United States), Public | Developer of small molecule drugs for diffrent health diseases | - | New Enterprise Associates, Bay City CapitalÌý&²¹³¾±è;Ìý | 60/100 |
9th | Denovo Biopharma 2013, San Diego (United States), Series D | Developer of genomic biomarker discovery platform | $172M | CICC, Goldstone Investment Ìý&²¹³¾±è;Ìý | 59/100 |
10th | Provider of a technology platform for the discovery of antibody-based drugs | $180M | Sequoia Capital, IDG CapitalÌý&²¹³¾±è;Ìý | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Metabolon's competitors? Click to see the top ones
Metabolon's Investments and acquisitions
Metabolon has made no investments or acquisitions yet.
Reports related to Metabolon
Here is the latest report on Metabolon's sector:
View
News related to Metabolon
Media has covered Metabolon for a total of 11 events in the last 1 year, 7 of them have been about company updates and 1 about people movement.
•
CNW•Apr 29, 2025•Metabolon
•
CNW•Jan 14, 2025•Metabolon
•
CNW•Nov 12, 2024•Metabolon
•
CNW•Oct 14, 2024•Metabolon
•
CNW•Sep 17, 2024•Metabolon
•
CNW•Jul 16, 2024•Metabolon
•
CNW•Jun 25, 2024•Metabolon
•
CNW•May 30, 2024•Metabolon
•
CNW•May 28, 2024•Metabolon
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Metabolon
When was Metabolon founded?
Metabolon was founded in 2000.Where is Metabolon located?
Metabolon is located in Morrisville, United States.When was the latest funding round of Metabolon?
Metabolon's latest funding round was on Dec 31, 2024.What is the annual revenue of Metabolon?
Annual revenue of Metabolon is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Vedic Tourism - India based, Unfunded company
- BLDG Ventures - Miami based, 2020 founded, Unfunded company
- Phone Master - Bengaluru based, Unfunded company
- Solanki Public School - Delhi based, 1988 founded, Unfunded company
- Mvmgonda - India based, 1992 founded, Unfunded company
- Mvmambikapur - India based, 2000 founded, Unfunded company
